T1	Participants 97 153	invasive aspergillosis in high-risk haematology patients
T2	Participants 257 316	haematology patients at high risk of invasive aspergillosis
T3	Participants 639 773	adults undergoing allogeneic stem-cell transplantation or chemotherapy for acute leukaemia, with no history of invasive fungal disease
